Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Simonini

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|December 21, 2004
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status?F Perfetto, R Tarquini, G Simonini, et al.
Clinical and Experimental Rheumatology|July 10, 2002
Kawasaki's disease in northern Italy: a multicenter retrospective study of 250 patientsF Falcini, R Cimaz, G B Calabri, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1993
[The Nissenkorn endourethral prosthesis: our experience]P Mancini, M G Cuttano, F Ponti, et al.
International Journal of Immunopathology and Pharmacology|April 18, 2012
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki diseaseG Guggino, R Cimaz, S Accomando, et al.
Molecular and Cellular Biochemistry|August 17, 1999
Oxidative stress in Systemic SclerosisG Simonini, M M Cerinic, S Generini, et al.
Toxicology|January 13, 2001
Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosisG Simonini, A Pignone, S Generini, et al.
Clinical and Experimental Rheumatology|November 18, 2009
Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatmentL Cantarini, O M Lucherini, M Galeazzi, et al.
Annals of the Rheumatic Diseases|June 25, 2002
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritisT Avcin, R Cimaz, F Falcini, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)L Cantarini, L Obici, G Simonini, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literatureL Cantarini, D Rigante, O M Lucherini, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|December 21, 2004
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status?F Perfetto, R Tarquini, G Simonini, et al.
Clinical and Experimental Rheumatology|July 10, 2002
Kawasaki's disease in northern Italy: a multicenter retrospective study of 250 patientsF Falcini, R Cimaz, G B Calabri, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1993
[The Nissenkorn endourethral prosthesis: our experience]P Mancini, M G Cuttano, F Ponti, et al.
International Journal of Immunopathology and Pharmacology|April 18, 2012
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki diseaseG Guggino, R Cimaz, S Accomando, et al.
Molecular and Cellular Biochemistry|August 17, 1999
Oxidative stress in Systemic SclerosisG Simonini, M M Cerinic, S Generini, et al.
Toxicology|January 13, 2001
Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosisG Simonini, A Pignone, S Generini, et al.
Clinical and Experimental Rheumatology|November 18, 2009
Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatmentL Cantarini, O M Lucherini, M Galeazzi, et al.
Annals of the Rheumatic Diseases|June 25, 2002
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritisT Avcin, R Cimaz, F Falcini, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)L Cantarini, L Obici, G Simonini, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literatureL Cantarini, D Rigante, O M Lucherini, et al.
Pageof 5